Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL820585 | 0.97 | MAPT (0.41) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| SCHEMBL13490255 | 0.82 | NPSR1 (0.40) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| Bromide SCHEMBL1884091 | 0.80 | ALDH1A1 (0.34) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| Hydrochloric Acid SCHEMBL28977637 | 0.78 | MAPT (0.33) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| Bromide SCHEMBL1883012 | 0.77 | DHFR (0.33) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| SCHEMBL20414976 | 0.74 | ALDH1A1 (0.41) | MAPTTDP1NPSR1LMNAMGLL | |
| SCHEMBL4272763 | 0.74 | LMNA (0.42) | MAPTLMNAF2ELANEADRB1 | |
| SCHEMBL4760153 | 0.74 | ALDH1A1 (0.40) | MAPTNPSR1LMNAL3MBTL1TSHR | |
| SCHEMBL18964692 | 0.73 | ALDH1A1 (0.50) | MAPTTDP1NPSR1LMNAL3MBTL1 | |
| SCHEMBL9678667 | 0.72 | ADRB1 (0.56) | MAPTTDP1NPSR1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112805313-B | Low density curable compositions | SIKA技术股份公司 | 2023-02-28 | — | — | CN | disclosed |
| EP-2826802-B1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORP (JP) | 2021-03-10 | — | — | EP | disclosed |
| EP-2574187-B1 | SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME | AMYRIS INC (US) | 2019-09-11 | — | — | EP | disclosed |
| CN-108864198-A | One kind is used as transient metal complex and its application of phosphor material | 烟台显华光电材料研究院有限公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108676037-A | One kind is used as transient metal complex and its application of phosphor material | 烟台显华光电材料研究院有限公司 | 2018-10-19 | — | — | CN | disclosed |
| CN-108676038-A | One kind is used as transient metal complex and its application of phosphor material | 烟台显华光电材料研究院有限公司 | 2018-10-19 | — | — | CN | disclosed |
| CN-108440605-A | One kind is used as transient metal complex and its application of phosphor material | 烟台显华光电材料研究院有限公司 | 2018-08-24 | — | — | CN | disclosed |
| US-20180127520-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9850325-B2 | Method for producing ring-opening metathesis polymer hydride, and resin composition | ZEON CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| EP-2116302-B1 | Catalyst complex with a heterocyclic carbene ligand | UNIV OF NEW ORLEANS FOUND (US) | 2017-02-22 | — | — | EP | disclosed |
| US-20040210055-A1 | stable to air, moisture, and thermal degradation; for olefin metathesis | NOLAN STEVEN P | 2004-10-21 | — | — | US | disclosed |
| US-6613851-B1 | Cyclic carbene- eta -ligand complexes for catalysis of olefin polymerization. | BOREALIS TECHNOLOGY OY (FI) | 2003-09-02 | — | — | US | disclosed |
| US-20030050406-A1 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-20030018138-A1 | Copolymer formed by ring -opening polymerization, product of hydrogenation of copolymer formed by ring-opening polymerization, and process for producing these | ZEON CORPORATION (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1275675-A1 | COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE | Zeon Corporation (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6486264-B1 | Process for producing hydrogenated ring-opening polymerization polymer of cycloolefin | ZEON CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| EP-1115491-A4 | CATALYST COMPLEX WITH CARBENE LIGAND | UNIV NEW ORLEANS FOUNDATION (US) | 2002-11-20 | — | — | EP | disclosed |
| EP-1197509-A1 | PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | Nippon Zeon Co., Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |
| EP-1115491-A1 | CATALYST COMPLEX WITH CARBENE LIGAND | University Of New Orleans Foundation (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000015339-A1 | CATALYST COMPLEX WITH CARBENE LIGAND | UNIVERSITY OF NEW ORLEANS FOUNDATION (US) | 2000-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210055-A1 | stable to air, moisture, and thermal degradation; for olefin metathesis | MDM2, MYC, MYCBP | MAPT 2028/4885TDP1 4125/4885NPSR1 3307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.